Analyst Price Targets — VRNS
| Date | Analyst | Firm | Target | Price @ Post | Source | Headline |
|---|---|---|---|---|---|---|
| February 4, 2026 9:27 pm | — | D.A. Davidson | $30.00 | $23.67 | TheFly | Varonis upgraded to Buy from Neutral at DA Davidson |
| February 4, 2026 2:42 pm | — | Truist Financial | $34.00 | $23.98 | TheFly | Varonis price target lowered to $34 from $42 at Truist |
| February 4, 2026 2:13 pm | Roger Boyd | UBS | $30.00 | $24.28 | TheFly | Varonis price target lowered to $30 from $60 at UBS |
| February 4, 2026 1:20 pm | Matthew Hedberg | RBC Capital | $30.00 | $21.45 | TheFly | Varonis price target lowered to $30 from $41 at RBC Capital |
| February 4, 2026 12:42 pm | — | Morgan Stanley | $27.00 | $26.53 | TheFly | Varonis price target lowered to $27 from $41 at Morgan Stanley |
| February 4, 2026 12:36 pm | — | Robert W. Baird | $32.00 | $26.53 | TheFly | Varonis price target lowered to $32 from $42 at Baird |
| February 4, 2026 12:21 pm | Mike Cikos | Needham | $30.00 | $26.53 | TheFly | Varonis price target lowered to $30 from $55 at Needham |
| February 4, 2026 10:55 am | — | Barclays | $38.00 | $26.53 | TheFly | Varonis price target lowered to $38 from $45 at Barclays |
| January 26, 2026 1:02 pm | — | UBS | $50.00 | $34.98 | StreetInsider | Varonis Systems (VRNS) PT Lowered to $50 at JPMorgan |
| January 26, 2026 10:07 am | — | Morgan Stanley | $41.00 | $34.95 | TheFly | Varonis downgraded to Equal Weight from Overweight at Morgan Stanley |
Latest News for VRNS
Coherent is expected to continue to benefit from a transition to products that enable faster throughput speeds, while prior constraints on manufacturing capacity appear to be alleviating. BrightSpring Health Services reported another strong quarter with both revenues and EBITDA up significantly, far outpacing its historical growth rate prior to going public in 2024. Varonis Systems, which provides data protection…
LOS ANGELES, March 02, 2026 (GLOBE NEWSWIRE) -- The Schall Law Firm , a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Varonis Systems, Inc. (“Varonis” or “the Company”) (NASDAQ: VRNS) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased…
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Varonis To Contact Him Directly To Discuss Their Options If you purchased or acquired securities in Varonis between February 4, 2025 and October 28, 2025 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). [You may…
SAN FRANCISCO, March 02, 2026 (GLOBE NEWSWIRE) -- National shareholder rights law firm Hagens Berman is notifying investors in Varonis Systems, Inc. (NASDAQ: VRNS) regarding the approaching March 9, 2026, lead plaintiff deadline in a pending securities class action lawsuit that has been filed against the company and certain of its executives. As alleged in the suit, the firm is examining whether Varonis executives…
LOS ANGELES, March 02, 2026 (GLOBE NEWSWIRE) -- The Law Offices of Frank R. Cruz reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded companies. Investors have until the deadlines listed below to file a lead plaintiff motion.
🧮 Earnings Move Analyzer
Insider Trading
Insider Trading
| Name | Role | Date | Type | Shares | Price | Form | Link |
|---|
Senate Trading
No Senate trades found for VRNS.
U.S. House Trading
House Trades Disclosures
| Name | Transaction Date | Type | Asset | Amount | Link |
|---|
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.